For patients with advanced BCC previously treated with HHIs

Spider plot depicting the percentage change from baseline in target lesions in responding patients with advanced BCC1


For a patient to be assessed at least a partial response (PR) for target lesion evaluation, there had to be at least a 50% reduction in the sum of target lesion diameters by WHO.2

  • BCC=basal cell carcinoma; HHI=hedgehog inhibitor; WHO=World Health Organization.